Ablative Solutions, Inc. Announces Completion Of The Fourth Tranche Of Its Series D Preferred Financing Round For Unique Therapeutic Approach To Treating Uncontrolled Hypertension
Round Type
Series D
WakefieldHealthcareHealth CareDescription
Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of the fourth tranche of its Series D financing round, resulting in $91.4 million in aggregate proceeds to the Company from the Series D financing round. Gilde Healthcare, BioStar Capital, Invus Opportunities and an undisclosed strategic corporate investor led the multi-tranched Series D round of financing.
Who to call at Ablative Solutions, and when
A new round usually means Ablative Solutions is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ablative Solutions raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ablative Solutions, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ablative Solutions. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ablative Solutions raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ablative Solutions raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.